Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
Net Income (Common)
Hana Pharm Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
Net Income (Common)
₩21.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Net Income (Common)
₩69.6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-2%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Net Income (Common)
₩240.7B
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Net Income (Common)
₩121.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Net Income (Common)
-₩10.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Net Income (Common)
₩16.5B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
81%
|
CAGR 10-Years
16%
|
|
Hana Pharm Co Ltd
Glance View
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.
See Also
What is Hana Pharm Co Ltd's Net Income (Common)?
Net Income (Common)
21.3B
KRW
Based on the financial report for Dec 31, 2024, Hana Pharm Co Ltd's Net Income (Common) amounts to 21.3B KRW.
What is Hana Pharm Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-6%
Over the last year, the Net Income (Common) growth was -5%. The average annual Net Income (Common) growth rates for Hana Pharm Co Ltd have been -9% over the past three years , -6% over the past five years .
You don't have any saved screeners yet